Similar Posts
Would you give anthrax vaccine to a child? DHHS Secretary Sebelius would
I am honored to be on the board of the Alliance for Human Research Protection and to be working with its dynamic President, Vera Sharav, on stopping a dangerous trial of anthrax vaccine in healthy children. Why sacrifice healthy children for this purpose, when the vaccine does not even have a useful role in post-exposure prophylaxis…
Legal Ramifications of Declaring a Public Health Emergency
I noticed that 2 old posts of mine about the laws and regulations governing public health emergencies were getting a lot of attention this week. I thought I would post them again, as they may soon be relevant here, and are already relevant to Africans faced with quarantines, cordon sanitaires and other legal and physical…
An interview with KPFA from February 2022
Here’s an interview I did a little while ago. It chops off some of the final words in some sentences. My section starts at 38:40 https://soundcloud.com/kmudpublicaffairs/current-affairs-with-kpfas-david-rosenberg
What Does State of Emergency mean?
What exactly is a “state of emergency”? According to Association of State and Territorial Health Officials (ASTHO), state declarations “may also identify state rules and regulations that are waived or suspended during the emergency… They can include: Activation of statutory immunities and liability protections for those involved in response activities. Suspension and waiver of rules…
Merck’s Covid-19 Pill Heavily Used So Far Despite Concerns/ WSJ
President Biden didn’t mention Molnupiravir in his State of the Union address, confining his promise of COVID therapies toPfizer’s Paxlovid, the much more effective drug–but nonetheless, Merck’s Molnupiravir is being rolled out and used widely. How many people know it is only 30% effective (according to its manufacturer, which usually guarantees it is considerably less effective…
Ebola Treatment: $1 Million/patient here with 80% survival; $20/patient in Africa with 35% survival: we need to find the sweet spot between them, where doable medical care significantly raises survival
I have been desperately seeking ideas to get us to that sweet spot: where medical providers will know how to manage Ebola in Africa, and their treatments will keep most Ebola victims alive, while not costing a million dollars per patient, or more. I envision patients having access to lab tests, iv fluids, convalescent serum, automatic…
